Dose adjustment in renal impairment
Dose adjustment may be needed in kidney disease.
Leaflet FIBRYGA 2 g powder and solvent for solution for injection / infusion
- Product code:
- W72188001
- Indicated for:
- bleeding; coagulation disorders
- Route of administration:
- injectable / infusion
- Substance:
- human fibrinogen (anticoagulant)
- ATC
- B02BB01 — Blood and blood forming organs | Vitamin k and other hemostatics | Fibrinogen
Human fibrinogen is an essential blood protein used as a medication to treat or prevent bleeding in patients with fibrinogen deficiency, a rare condition that can be congenital or acquired. Fibrinogen plays a crucial role in blood clotting, helping to form the clots needed to stop bleeding.
Human fibrinogen is administered by intravenous infusion under the strict supervision of medical personnel. The dose and frequency of administration are determined by the doctor, depending on the severity of the deficiency and the patient's needs. Careful monitoring is essential to prevent complications.
Possible side effects include allergic reactions, fever, chills, or an increased risk of blood clots. In rare cases, severe reactions such as anaphylactic shock may occur. If you experience any unusual symptoms, contact your doctor immediately.
Human fibrinogen is vital for patients with bleeding disorders, but its use requires careful medical supervision. Inform your doctor about any other conditions or treatments you are undergoing to reduce the risk of complications.
General data about FIBRYGA 2 g
- Substance:
- human fibrinogen
- Product code:
- W72188001
- Concentration:
- 2g
- Pharmaceutical form:
- powder and solvent for solution for injection / infusion
- Product type:
- Generic medicine
- Prescription status:
- S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.
Pharmaceutical forms available for human fibrinogen
Concentrations available for human fibrinogen
- 1g
- 2g
Precautions:
Major drug interactions
This medicine may have important interactions with other medicines.
Additional monitoring
This medicine is subject to additional monitoring.
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.
Bleeding risk
This medicine may increase the risk of bleeding.